H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.


After recent emergence of new avian influenza A(H7N9) viruses in humans many people and Governments are asking about H7 influenza vaccine which could provide cross-protection against new viruses, until H7N9 vaccine is prepared from a relevant strain. Here we scientifically justify that available H7N3 live attenuated influenza vaccine (LAIV) can be… (More)
DOI: 10.1016/j.vaccine.2013.08.040


  • Presentations referencing similar topics